Literature DB >> 13575817

The role of anaphylatoxin during in vitro anaphylaxis.

S E GREISMAN.   

Abstract

Keywords:  ALLERGY/experimental

Mesh:

Substances:

Year:  1958        PMID: 13575817

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  8 in total

Review 1.  [ENZYMATIC PROCESSES IN THE PATHOGENESIS OF ALLERGIC REACTIONS].

Authors:  W RAAB; E KAISER
Journal:  Klin Wochenschr       Date:  1965-04-01

2.  The mechanism of protection from anaphylactic shock in the guinea-pig by pre-treatment with anaphylatoxin.

Authors:  O L FRICK; B N HALPERN; P LIACOPOULOS
Journal:  J Physiol       Date:  1962-09       Impact factor: 5.182

3.  [On the substance liberated in anaphylactic and allergic reaction].

Authors:  G ENGELHARDT; U SCHWABE
Journal:  Klin Wochenschr       Date:  1960-02-15

4.  [The theoretical principles of allergy].

Authors:  F HAHN; H GIERTZ
Journal:  Arch Ohren Nasen Kehlkopfheilkd       Date:  1960

5.  Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.

Authors:  Beatrix Schäfer; Adrian M Piliponsky; Tatsuya Oka; Chang Ho Song; Norma P Gerard; Craig Gerard; Mindy Tsai; Janet Kalesnikoff; Stephen J Galli
Journal:  J Allergy Clin Immunol       Date:  2012-06-22       Impact factor: 10.793

6.  Mechanism of histamine release from guinea-pig lung by soluble immune complexes. II. Role of anaphylatoxin.

Authors:  I Broder
Journal:  Immunology       Date:  1974-01       Impact factor: 7.397

7.  Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement.

Authors:  W Dias Da Silva; I H Lepow
Journal:  J Exp Med       Date:  1967-05-01       Impact factor: 14.307

8.  Studies on the mechanism of hypersensitivity phenomena. III. The participation of complement in the formation of anaphylatoxin.

Authors:  A G OSLER; H G RANDALL; B M HILL; Z OVARY
Journal:  J Exp Med       Date:  1959-08-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.